Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.
Kusumoto T, Sunami E, Ota M, Yoshida K, Sakamoto Y, Tomita N, Maeda A, Mochizuki I, Okabe M, Kunieda K, Yamauchi J, Itabashi M, Kotake K, Takahashi K, Baba H, Boku N, Aiba K, Ishiguro M, Morita S, Sugihara K.
Kusumoto T, et al. Among authors: sugihara k.
Clin Colorectal Cancer. 2018 Jun;17(2):e153-e161. doi: 10.1016/j.clcc.2017.10.015. Epub 2017 Nov 1.
Clin Colorectal Cancer. 2018.
PMID: 29249584
Free article.
Clinical Trial.